435 related articles for article (PubMed ID: 11345288)
1. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
[TBL] [Abstract][Full Text] [Related]
2. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray.
Gawchik S; Goldstein S; Prenner B; John A
Ann Allergy Asthma Immunol; 2003 Apr; 90(4):416-21. PubMed ID: 12722964
[TBL] [Abstract][Full Text] [Related]
3. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
[TBL] [Abstract][Full Text] [Related]
4. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
Ciprandi G; Cirillo I; Vizzaccaro A
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):146-50. PubMed ID: 15180356
[TBL] [Abstract][Full Text] [Related]
5. Effects of intranasal azelastine on the response to nasal allergen challenge.
Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM
Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037
[TBL] [Abstract][Full Text] [Related]
6. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
Benson M; Strannegård IL; Strannegård O; Wennergren G
J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
[TBL] [Abstract][Full Text] [Related]
7. Intranasal fluticasone propionate reduces ICAM-1 on nasal epithelial cells both during early and late phase after allergen challenge.
Ciprandi G; Ricca V; Passalacqua G; Fasolo A; Canonica GW
Clin Exp Allergy; 1998 Mar; 28(3):293-9. PubMed ID: 9543078
[TBL] [Abstract][Full Text] [Related]
8. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
Anolik R;
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
Lange B; Lukat KF; Rettig K; Holtappels G; Bachert C
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
[TBL] [Abstract][Full Text] [Related]
10. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis.
Frieri M; Therattil J; Chavarria V; Cosachov J; Kumar NS; Wang SF; Sansone G; Etzel J; Dellevecchia D; Zitt M; Mesarina-Wicki B; Nolop KB
Ann Allergy Asthma Immunol; 1998 Nov; 81(5):431-7. PubMed ID: 9860036
[TBL] [Abstract][Full Text] [Related]
11. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
Jen A; Baroody F; de Tineo M; Haney L; Blair C; Naclerio R
J Allergy Clin Immunol; 2000 Apr; 105(4):732-8. PubMed ID: 10756223
[TBL] [Abstract][Full Text] [Related]
12. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity.
Ciprandi G; Tosca M; Ricca V; Passalacqua G; Riccio AM; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1160-6. PubMed ID: 9383256
[TBL] [Abstract][Full Text] [Related]
13. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis.
Bernstein DI; Teper A; Gopalan G; Gates D
Ann Allergy Asthma Immunol; 2012 May; 108(5):359-62. PubMed ID: 22541408
[TBL] [Abstract][Full Text] [Related]
14. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
[TBL] [Abstract][Full Text] [Related]
15. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma.
Pedroletti C; Lundahl J; Alving K; Hedlin G
Pediatr Allergy Immunol; 2008 May; 19(3):219-26. PubMed ID: 18399898
[TBL] [Abstract][Full Text] [Related]
16. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
[TBL] [Abstract][Full Text] [Related]
18. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
Baroody FM; Shenaq D; DeTineo M; Wang J; Naclerio RM
J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of mometasone furoate nasal spray in seasonal allergic rhinitis. First experiences in practice after the introduction of the drug in Hungary].
Farkas H; Pintér J; Kalabay L; Jakab L; Visy B; Fekete B
Orv Hetil; 2002 Aug; 143(33):1929-33. PubMed ID: 12244656
[TBL] [Abstract][Full Text] [Related]
20. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate.
Bielory L
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):272-9. PubMed ID: 18434976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
